116 related articles for article (PubMed ID: 38241069)
21. Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.
Sławiński J; Gdaniec M
Eur J Med Chem; 2005 Apr; 40(4):377-89. PubMed ID: 15804537
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro antitumor activity of new series of benzothiazole and pyrimido[2,1-b]benzothiazole derivatives.
Gabr MT; El-Gohary NS; El-Bendary ER; El-Kerdawy MM
Eur J Med Chem; 2014 Oct; 85():576-92. PubMed ID: 25127150
[TBL] [Abstract][Full Text] [Related]
24. Novel N-(aryl/heteroaryl)-2-chlorobenzenesulfonamide derivatives: Synthesis and anticancer activity evaluation.
Bułakowska A; Sławiński J; Siedlecka-Kroplewska K; Stasiłojć G; Serocki M; Heldt M
Bioorg Chem; 2020 Nov; 104():104309. PubMed ID: 33011532
[TBL] [Abstract][Full Text] [Related]
25. Hit to lead optimization of a series of N-[4-(1,3-benzothiazol-2-yl)phenyl]acetamides as monoacylglycerol lipase inhibitors with potential anticancer activity.
Afzal O; Akhtar MS; Kumar S; Ali MR; Jaggi M; Bawa S
Eur J Med Chem; 2016 Oct; 121():318-330. PubMed ID: 27267002
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
27. Discovery of Novel 3,4-Dihydro-2(1
Ma J; Gong GH
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268645
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Characterization, Antiproliferative Activity of Galloyl Derivatives and Investigation of Cytotoxic Properties in HepG2/C3A Cells.
Dos Santos RC; de Freitas RON; Foglio MA; de Carvalho JE; Ruiz ALTG; Pessatto LR; Oliveira RJ; Baranoski A; Biazi BI; Mantovani MS; Kassuya CAL; de Oliveira Junior PC; Formagio ASN
Curr Pharm Biotechnol; 2022; 23(13):1623-1633. PubMed ID: 34923937
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticancer activity of new thiazolo[3,2-a]pyrimidines: DNA binding and molecular modeling study.
Hassan GS; El-Messery SM; Abbas A
Bioorg Chem; 2017 Oct; 74():41-52. PubMed ID: 28750204
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2015 Jan; 90():45-52. PubMed ID: 25461310
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons.
Ahmed EM; Khalil NA; Zaher AF; Alhamaky SM; El-Zoghbi MS
Bioorg Chem; 2021 Jul; 112():104915. PubMed ID: 33905973
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.
Kachaeva MV; Hodyna DM; Semenyuta IV; Pilyo SG; Prokopenko VM; Kovalishyn VV; Metelytsia LO; Brovarets VS
Comput Biol Chem; 2018 Jun; 74():294-303. PubMed ID: 29698921
[TBL] [Abstract][Full Text] [Related]
33. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
34. Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF
Ali EMH; Mersal KI; Ammar UM; Zaraei SO; Abdel-Maksoud MS; El-Gamal MI; Haque MM; Das T; Kim EE; Lee JS; Lee KH; Kim HK; Oh CH
Eur J Pharm Sci; 2022 Apr; 171():106115. PubMed ID: 34995782
[TBL] [Abstract][Full Text] [Related]
35. Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.
Elbadawi MM; Eldehna WM; Wang W; Agama KK; Pommier Y; Abe M
Eur J Med Chem; 2021 Apr; 215():113261. PubMed ID: 33631697
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.
Rathore P; Yaseen S; Ovais S; Bashir R; Yaseen R; Hameed AD; Samim M; Gupta R; Hussain F; Javed K
Bioorg Med Chem Lett; 2014 Apr; 24(7):1685-91. PubMed ID: 24630557
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAF
Ali EMH; Abdel-Maksoud MS; Ammar UM; Mersal KI; Ho Yoo K; Jooryeong P; Oh CH
Bioorg Chem; 2021 Jan; 106():104508. PubMed ID: 33280830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]